Lepu Biopharma Signs CDMO Services Framework Agreement with Lepu Medical
Lepu Biopharma Co. Ltd. has signed a CDMO Services Framework Agreement with Lepu Medical to provide contract development and manufacturing services. This agreement supports Lepu Medical's clinical trial development and production registration needs, including clinical drug supply and batch production. The agreement specifies service volumes and costs based on Lepu Medical's requirements. The original content was published by Lepu Biopharma via the Hong Kong Stock Exchange's Issuer Information Service.
Lepu Biopharma Co. Ltd. announced that it has entered into a CDMO Services Framework Agreement with Lepu Medical. Under this agreement, Lepu Biopharma will provide contract development and manufacturing organization (CDMO) services to Lepu Medical and its subsidiaries. The services will support the clinical trial development and production registration needs of Lepu Medical’s drug candidates, including clinical drug supply, batch release testing, and pre-approval inspection batch production. The agreement outlines the anticipated service volumes and associated costs based on the needs of Lepu Medical and its subsidiaries. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lepu Biopharma Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251128-11931803), on November 28, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)
